One-year course of the first vs. multiple episodes of depression - Polish naturalistic study

European Psychiatry

Volumn 19, Issue 5, 2004, Pages 258-263

  Rybakowski, Janusz K ^a   Nawacka, Dorota ^b   Kiejna, Andrzej ^c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Servier Polska   (Poland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Depression; Hamilton depression rating scale (HDRS); Polish naturalistic study; Remission

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; DIBENZEPIN; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIANSERIN; MILNACIPRAN; MOCLOBEMIDE; OPIPRAMOL; PAROXETINE; SERTRALINE; TIANEPTINE;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; FEMALE; GENDER; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHIATRIST; REMISSION; SCORING SYSTEM; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVATION; POLAND; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUESTIONNAIRES; RECURRENCE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 3342983303     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2004.06.004     Document Type: Article

References (23)

1. Angst J. The course of affective disorders. Psychopathology. 19:1986;47-52
2. Ballenger J.C. Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatry. 60:(Suppl 22):1999;29-34
3. Donoghue J., Hylan T.R. Antidepressant use in clinical practice: efficacy vs. effectiveness. Br J Psychiatry. 179:(Suppl 42):2001;s9-s17
4. Ferrier I.N. Treatment of major depression: is improvement enough? J Clin Psychiatry. 60:(Suppl 6):1999;10-14
5. Frank E., Prien R.F., Jarrett R.B., Keller M.B., Kupfer D.J., Lavori P.W., et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 48:1991;851-855
6. Geddes J.R., Carney S.M., Davies C., Furukawa T.A., Kupfer D.J., Frank E., et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 361:2001;653-661
7. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62
8. Hoencamp E., Haffmans P.M., Griens A.M., Huijbrechts I.P., Heycop ten Ham B.F. A 3.5-year naturalistic follow-up study of depressed out-patients. J Affect Disord. 66:2001;267-271
9. Judd L.L., Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W., et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry. 55:1998;694-700
10. Judd L.L., Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W., et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord. 50:1998;97-108
11. Kennedy S., McIntyre R., Fallu A., Lam R. Pharmacotherapy to sustain the fully remitted state. J Psychiatry Neurosci. 27:2002;269-280
12. Kupfer D.J., Frank E., Perel J.M. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 49:1992;769-773
13. Lieberman J.A., Sheitman B.B., Kinon B.J. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology. 17:1997;205-229
14. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet. 349:1997;1498-1504
15. Paykel E.S. Continuation and maintenance therapy in depression. Br Med Bull. 57:2001;145-159
16. Paykel E.S., Ramana R., Cooper Z., Hayhurst H., Kerr J., Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med. 25:1995;1171-1180
17. Prien R.F., Kupfer D.J. Continuation drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry. 143:1986;18-23
18. Ramana R., Paykel E.S., Cooper Z., Hayhurst H., Saxty M., Surtees P.G. Remission and relapse in major depression: a 2-year prospective follow-up study. Psychol Med. 25:1995;1161-1170
19. Rybakowski J.K., Twardowska K. The dexamethasone/corticotrophin releasing hormone test in depression in unipolar and bipolar affective illness. J Psychiatr Res. 33:1999;363-370
20. Shea T., Leon A., Mueller T., Solomon D.A., Warshaw M.G., Keller M.B. Does major depression result in lasting personality change? Am J Psychiatry. 153:1996;1404-1410
21. Solomon D.A., Keller M.B., Leon A.C., Mueller T.I., Shea M.T., Warshaw M., et al. Recovery from major depression: a 10-year prospective follow-up across multiple episodes. Arch Gen Psychiatry. 54:1997;1001-1006
22. The World Health Report 2001. Mental health: new understanding, new hope. 2001;World Health Organization,, Geneva
23. Weiss S.R., Post R.M. Kindling: separate vs. shared mechanisms in affective disorders and epilepsy. Neuropsychobiology. 38:1998;167-180